Leukemia Clinical Trials
Leukemia clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for leukemia. Corterve aggregates actively recruiting Leukemia studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Leukemia studies
- A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaNCT05645107PHASE3Grifols Therapeutics LLCHuntington Park, California
- Personalized NK Cell Therapy in CBTNCT02727803PHASE2M.D. Anderson Cancer CenterHouston, Texas
- Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer TreatmentNCT01087333National Cancer Institute (NCI)Bethesda, Maryland
- A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)NCT06943872PHASE3BeOne MedicinesLaguna Hills, California
- A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...NCT05621291NANational Cancer Institute (NCI)Los Angeles, California
- Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaNCT07191119NASt. Jude Children's Research HospitalMemphis, Tennessee
- Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRDNCT07566364PHASE2M.D. Anderson Cancer CenterHouston, Texas
- Tissue Collection for Studies of Lymph CancerNCT01676805National Cancer Institute (NCI)Bethesda, Maryland
- Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy ProtocolsNCT02682667National Cancer Institute (NCI)Bethesda, Maryland
- First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.NCT07586618PHASE1Allterum Therapeutics, IncAurora, Colorado
- Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...NCT02390752PHASE1National Cancer Institute (NCI)Bethesda, Maryland
- CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell MalignanciesNCT05442515PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
Leukemia trials by state
Leukemia trials by metro
Frequently asked questions
- How do I find recruiting Leukemia clinical trials?
- Corterve aggregates actively recruiting Leukemia studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Leukemia clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Leukemia clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.